301201 logo

ChengDa Pharmaceuticals Co., Ltd. Stock Price

SZSE:301201 Community·CN¥6.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

301201 Share Price Performance

CN¥43.77
24.88 (131.71%)
CN¥43.77
24.88 (131.71%)
Price CN¥43.77

301201 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
0 Rewards

ChengDa Pharmaceuticals Co., Ltd. Key Details

CN¥374.5m

Revenue

CN¥225.4m

Cost of Revenue

CN¥149.1m

Gross Profit

CN¥200.8m

Other Expenses

-CN¥51.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 28, 2026
-0.34
39.81%
-13.81%
2.7%
View Full Analysis

About 301201

Founded
1980
Employees
656
CEO
Gang Lu
WebsiteView website
www.chengdapharm.com

ChengDa Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and food and feed additives in China and internationally. It offers process research and development, process optimization, quality and stability research, customized production and other services for pharmaceutical intermediates and APIs; and food and feed additives, such as L-carnitine and L-carnitine tartrate. The company also provides bulk drug products, including urogenital, nervous system, blood and hematopoietic organs, muscular system, digestive tract and metabolism, antineoplastic and immunomodulators; and pharmaceutical intermediates comprising drug intermediates for blood and hematopoietic organs, drug intermediates in digestive tract and metabolism, and nervous system drug intermediates. ChengDa Pharmaceuticals Co., Ltd. was founded in 1980 and is based in Jiaxing, China.

Recent 301201 News & Updates

Recent updates

No updates